Piper Jaffray Initiates Coverage on Watson Pharmaceuticals (WPI) with an Underweight; Hard to Envision Significant Organic Growth

Piper Jaffray Initiates Coverage on Watson Pharmaceuticals (WPI) with an Underweight; Hard to Envision Significant Organic Growth
StreetInsider.com - 24 minutes ago
Piper Jaffray initiates coverage on Watson Pharmaceuticals (NYSE: WPI) with an Underweight rating. Price target $34. Piper analyst says, "Though Watson has now established an ex-US presence for ...